Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hannah Y. Wen
Assessment of Dual-Probe Her-2 Fluorescent in Situ Hybridization in Breast Cancer by the 2013 ASCO/CAP Guidelines Produces More Equivocal Results Than That by the 2007 ASCO/CAP Guidelines
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
JAMA Oncology
Cancer Research
Oncology
Quantitative Assessments and Clinical Outcomes in HER2 Equivocal 2018 ASCO/CAP ISH Group 4 Breast Cancer
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
HER2-ASCO-Guidelines
Der Pathologe
Forensic Medicine
Pathology
Breast Cancer News From ASCO 2013
Breast Care
Surgery
Oncology
ASCO 2015: Highlights in Breast Cancer
Memo - Magazine of European Medical Oncology
Oncology
Hematology
Strong Correlation Between Results of Fluorescent in Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast Carcinoma
Modern Pathology
Forensic Medicine
Pathology
Searching for ROS1 Rearrangements in Lung Cancer by Fluorescent in Situ Hybridization: The Importance of Probe Design
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
2007 EORTC-NCI-ASCO Annual Meeting. Molecular Markers in Cancer
ecancermedicalscience
Cancer Research
Oncology
